CPHI Milan 2026
10/2026 – 10/2026
About Company
- Legal Name: Dongkook Pharmaceutical Co., Ltd.
- Registered country: Republic of Korea
- Address: 715, Yeongdong-daero,, Gangnam-gu, Seoul
- Number of employees: 1000 - 4999
Description:
Founded in 1968, Dongkook Pharmaceutical has concentrated on R&D and technology innovation, becoming well known for high-brand-value OTC products in Korea, alongside developing and producing therapeutic products including anesthetics, contrast media and anti-cancer agents. The company is recognized by domestic and foreign authorities for the quality of its finished products, medical devices and APIs, and currently exports finished products, medical devices and APIs internationally.
Business Activities
Contract & Outsourcing Services
Manufacturer
Finished Dosage Forms
Manufacturer
ATC (Anatomical Therapeutic Chemical) Classification
Manufacturer
Innovator APIs
Manufacturer
Key Products/Services
- Contract & Outsourcing Services: Teicoplanin
- Finished Dosage Forms: Donepezil Depot Injection
- ATC (Anatomical Therapeutic Chemical) Classification: Liposomal Amphotericn B Injection, Leuprolide Acetate Injection, Leuprolide Acetate Depot Injection, Propofol Injection, Dexmedetomidine Hydrochloride Injection, Octreotide Acetate LAR Injection
Our Products & Services
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Proofs
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment